MIAN, Michael
 Distribuzione geografica
Continente #
NA - Nord America 149
AS - Asia 129
EU - Europa 82
SA - Sud America 37
AF - Africa 4
Totale 401
Nazione #
US - Stati Uniti d'America 144
CN - Cina 44
SG - Singapore 41
BR - Brasile 28
HK - Hong Kong 18
GB - Regno Unito 16
IE - Irlanda 14
FR - Francia 13
VN - Vietnam 13
RU - Federazione Russa 12
SE - Svezia 9
DE - Germania 5
UA - Ucraina 5
BD - Bangladesh 3
BE - Belgio 3
EC - Ecuador 3
KR - Corea 3
AR - Argentina 2
CA - Canada 2
CO - Colombia 2
ID - Indonesia 2
MX - Messico 2
AT - Austria 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
IQ - Iraq 1
IT - Italia 1
LT - Lituania 1
MA - Marocco 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
TG - Togo 1
TR - Turchia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 401
Città #
Dallas 35
Singapore 21
Hong Kong 18
Jacksonville 16
Dublin 14
Southend 14
Chandler 12
Beijing 8
Wilmington 7
New York 6
Ashburn 5
Ho Chi Minh City 5
Jinan 5
The Dalles 5
Houston 4
Lawrence 4
Princeton 4
Brussels 3
Columbus 3
Frankfurt am Main 3
Hanoi 3
Hebei 3
Nanjing 3
Ann Arbor 2
Guayaquil 2
Haikou 2
Los Angeles 2
Mogi das Cruzes 2
Nanchang 2
Pelotas 2
Ribeirão Preto 2
San Francisco 2
Seattle 2
Seoul 2
Shenyang 2
Tianjin 2
Arraial do Cabo 1
Asunción 1
Avellaneda 1
Barranquilla 1
Bauru 1
Belo Horizonte 1
Belém 1
Bogotá 1
Braço do Norte 1
Cotia 1
Council Bluffs 1
Cupira 1
Curitiba 1
Dearborn 1
Ensenada 1
Fes 1
Franca 1
Fuzhou 1
Gaza 1
Goma 1
Gravataí 1
Guarulhos 1
Hangzhou 1
Hyderabad 1
Ibiapina 1
Jakarta 1
Johannesburg 1
Jojutla 1
Lanús 1
Lisbon 1
Lomé 1
London 1
Madhyapara 1
Marcolândia 1
Matipó 1
Montreal 1
Ningbo 1
Ottawa 1
Pedro Leopoldo 1
Phủ Lý 1
Probolinggo 1
Quito 1
Quận Ba 1
Quận Hai 1
Roubaix 1
San José 1
Santa Clara 1
Santo Antônio dos Lopes 1
Sapiranga 1
São Paulo 1
Tashkent 1
Teresópolis 1
Teófilo Otoni 1
Thái Nguyên 1
Thủ Đức 1
Viana 1
Vigasio 1
Votorantim 1
Wroclaw 1
Zhengzhou 1
Totale 287
Nome #
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 91
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma 83
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent 65
Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients 54
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study) 54
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study) 46
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG) 15
Totale 408
Categoria #
all - tutte 1.755
article - articoli 1.755
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 3 5 4 4 0 0 0 0 4 1
2021/202227 1 4 0 0 0 1 0 2 3 2 3 11
2022/202362 4 5 9 6 4 20 0 3 5 1 5 0
2023/202444 1 7 0 1 5 9 3 4 0 2 6 6
2024/202599 5 7 2 16 3 7 1 5 11 10 9 23
2025/2026112 26 85 1 0 0 0 0 0 0 0 0 0
Totale 408